Taejon, South Korea

Byung-Ho Lee

This inventor holds 6 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents. Top assignees: Korea Research Institute of Chemical Technology, Daewoo Electronics Co., Ltd., Dongbu Hannong Chemical Co., Ltd.. Active years: 1997-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Byung-Ho Lee. Retrieved from https://idiyas.com/inventor/byung-ho-lee-ydebvphz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 66.7



Average Co-Inventor Count = 12.0

ph-index = 2

Forward Citations = 16(Granted Patents)


Location History:

  • Daejeon, KR (1997 - 1998)
  • Taejon-si, KR (2008)
  • Taejeon-si, KR (2007 - 2012)

Company Filing History:


Years Active: 1997-2012

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Byung-Ho Lee: Innovator in Pharmaceutical Chemistry

Introduction

Byung-Ho Lee is a prominent inventor based in Taejeon-si, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic applications in treating ischemic heart diseases and cerebrovascular conditions. With a total of six patents to his name, Lee's work demonstrates a commitment to advancing medical science.

Latest Patents

One of Lee's latest patents involves benzothiophen-2-carbonylguanidine derivatives, which have shown a potent inhibitory effect on the sodium/hydrogen exchanger NHE-I. These derivatives improve functional recovery from ischemia/reperfusion-induced heart injury and significantly reduce myocardial infarct size in animal models. They also exhibit protective effects on neuronal cells, making them valuable for treating ischemic heart diseases and cerebrovascular diseases. Another notable patent focuses on benzopyran derivatives substituted with secondary amines, including tetrazole. These compounds are designed to protect neuronal cells, inhibit nitric oxide generation, and preserve organs during major cardiovascular surgeries.

Career Highlights

Throughout his career, Byung-Ho Lee has worked with esteemed organizations such as the Korea Research Institute of Chemical Technology and Dongbu Hannong Chemical Co., Ltd. His research has led to innovative solutions that address critical health issues, particularly in cardiology and neurology.

Collaborations

Lee has collaborated with notable colleagues, including Sung-Eun Yoo and Kyu-Yang Yi. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Byung-Ho Lee's contributions to pharmaceutical chemistry highlight his role as an innovator dedicated to improving health outcomes through his inventions. His work continues to influence the fields of cardiology and neurology, showcasing the importance of research and innovation in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…